Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Ligands for aggregated tau molecules

A helical, self-contained technique in the field of ligands for neuropathic staging

Active Publication Date: 2011-10-19
WISTA LAB LTD
View PDF6 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

EEG-neurological diagnostic methods have been developed (see e.g. Vargha-Khadem, F. et al. (1997); Willingham, D.B. (1997); Lakmache, Y. et al. (1995); and Hodges, J.R. et al. (1999) ), but there is still a need in this regard for inexpensive instrumentation available in contact with the clinician

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ligands for aggregated tau molecules
  • Ligands for aggregated tau molecules
  • Ligands for aggregated tau molecules

Examples

Experimental program
Comparison scheme
Effect test

example

[0828] In one embodiment, the compound is selected from compounds of the following formulae and pharmaceutically acceptable salts, hydrates and solvates thereof.

[0829] Compounds, wherein -Q- is -NHC(O)-; -NR 1 C(O)-; -C(O)NH-; or -C(O)NR 1 -.

[0830] Benzothiazole compounds

[0831] Non-fluorinated methoxy-amides

[0832]

[0833]

[0834]

[0835] In one embodiment, the compounds are independently selected from:

[0836] ABMA-04; ABMA-05; ABMA-06; ABMA-07; ABMA-08; ABMA-09; ABMA-10; ABMA-11; ABMA-13; ABMA-14; ABMA-15; and ABMA-16.

[0837] In one embodiment, the compounds are independently selected from:

[0838] ABMA-04; ABMA-05; ABMA-06; ABMA-07; ABMA-08; ABMA-09; ABMA-10; ABMA-11; and ABMA-13.

[0839] Fluorinated methoxy-amide

[0840]

[0841]

[0842]

[0843] In one embodiment, the compounds are independently selected from:

[0844] ABFMA-04; ABFMA-05; ABFMA-06; ABFMA-07; ABFMA-08; ABFMA-09; ABFMA-11; ABFMA-12; ABFMA-14; ABFMA-15;

[08...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Provided are certain benzothiazole, imidazothiazole, imidazopyrimidine and imidazopyridine compounds, including, for example:formula (I) and pharmaceutically and physiologically acceptable salts, hydrates, and solvates thereof. Such compounds can be used as diagnostic ligands or labels of tau protein and PHF.

Description

[0001] related application [0002] This application claims priority from US 61 / 099,376, filed September 23, 2008, the contents of which are hereby incorporated by reference in their entirety. technical field [0003] The present invention generally relates to materials, methods and models related to the labeling and detection of neurofibrillary tangles. Furthermore, the present invention relates to ligands suitable for neuropathological staging and their use in the diagnosis, prediction or treatment of diseases such as Alzheimer's disease (AD). Background technique [0004] In order to more fully describe and fully disclose this invention and the state of the art related to this invention, this application refers to various patents and publications. Each reference is incorporated into this specification by reference in its entirety, and each reference should be deemed to be individually and specifically incorporated by reference. [0005] Throughout this specification (in...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/68C07D275/04C07D277/66C07D279/06
CPCC07D277/66C07D417/12C07D471/04C07D487/04C07D513/04G01N2333/4709G01N2800/2821G01N33/6896Y10T436/17Y10T436/18Y10T436/147777Y10T436/14
Inventor 史蒂文·J·凯姆普琳达·J·斯托里约翰·M·D·斯托里詹内特·里卡德查尔斯·R·哈林顿克劳德·M·维希克斯科特·克鲁纳斯托拜厄斯·K·海因里克
Owner WISTA LAB LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products